Sign in
Enrolling by invitationNo phase

Long-term follow-up of people previously treated with NCI cell-based gene therapy

Follows people with melanoma or other cancers after earlier NCI gene therapy treatment.

Key facts

Who runs it
National Cancer Institute (NCI)
Where
Bethesda, United StatesSee the site
Trial code
Registry title
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Status
Enrolling by invitation
People taking part
1,150 people, planned
Started
15 Jun 2009
Type of study
Observational, 2 groups
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who cannot take part

  • -For Cohort B: Individuals of child-bearing potential (IOCBP) who are pregnant or plan to become pregnant because of the potentially dangerous effects of the investigational treatments administered on NCI-SB treatment protocols

Other criteria

  • INCLUSION CRITERIA:
  • Age greater than or equal to 18 years
  • Participants who have received treatment on an NCI-SB protocol, including gene therapy protocols. (Note: Participants may be enrolled on this protocol and, at the same time, participate in an active treatment study)
  • For Cohort A:Ability of participant or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document. For Cohort B: Participant is able to provide informed consent

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from participants' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.

Objective:

This study will allow participants to be followed for up to 15 years following treatment on an NCI Surgery Branch Gene Therapy Trial as required by the FDA.

Eligibility:

Participants must have been enrolled on an NCI Surgery Branch Gene Therapy Protocol

Design

Participants will be followed with a physical examination and blood tests for up to 15 years as required by the FDA

The 2 groups in the trial

  • A/Gene Therapy

    Patients who have received gene therapy

  • B/Non-Gene Therapy

    Patients who have not received gene therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Follow-Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Plain-language title
Long-term follow-up of people previously treated with NCI cell-based gene therapyGenerated from the registry record. The registry title is the official one.
Record updated
12 November 2026